Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Viral Characteristics Associated with Maintenance of Elite Neutralizing Activity in Chronically HIV-1 Clade C-Infected Monozygotic Pediatric Twins.

Mishra N, Makhdoomi MA, Sharma S, Kumar S, Dobhal A, Kumar D, Chawla H, Singh R, Kanga U, Das BK, Lodha R, Kabra SK, Luthra K.

J Virol. 2019 Aug 13;93(17). pii: e00654-19. doi: 10.1128/JVI.00654-19. Print 2019 Sep 1.


An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses.

Kumar S, Panda H, Makhdoomi MA, Mishra N, Safdari HA, Chawla H, Aggarwal H, Reddy ES, Lodha R, Kumar Kabra S, Chandele A, Dutta S, Luthra K.

J Virol. 2019 Feb 5;93(4). pii: e01495-18. doi: 10.1128/JVI.01495-18. Print 2019 Feb 15.


Challenges in integrating component level technology and system level information from Ayurveda: Insights from NMR phytometabolomics and anti-HIV potential of select Ayurvedic medicinal plants.

Jayasundar R, Ghatak S, Makhdoomi MA, Luthra K, Singh A, Velpandian T.

J Ayurveda Integr Med. 2019 Apr - Jun;10(2):94-101. doi: 10.1016/j.jaim.2017.06.002. Epub 2018 Jan 3.


Alterations in B Cell Compartment Correlate with Poor Neutralization Response and Disease Progression in HIV-1 Infected Children.

Aggarwal H, Khan L, Chaudhary O, Kumar S, Makhdoomi MA, Singh R, Sharma K, Mishra N, Lodha R, Srinivas M, Das BK, Kabra SK, Luthra K.

Front Immunol. 2017 Dec 1;8:1697. doi: 10.3389/fimmu.2017.01697. eCollection 2017.


CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children.

Kumar S, Kumar R, Khan L, Makhdoomi MA, Thiruvengadam R, Mohata M, Agarwal M, Lodha R, Kabra SK, Sinha S, Luthra K.

Front Immunol. 2017 Nov 15;8:1568. doi: 10.3389/fimmu.2017.01568. eCollection 2017.


Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India.

Makhdoomi MA, Khan L, Kumar S, Aggarwal H, Singh R, Lodha R, Singla M, Das BK, Kabra SK, Luthra K.

J Gen Virol. 2017 Jul;98(7):1879-1891. doi: 10.1099/jgv.0.000824. Epub 2017 Jul 12.


Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library.

Khan L, Kumar R, Thiruvengadam R, Parray HA, Makhdoomi MA, Kumar S, Aggarwal H, Mohata M, Hussain AW, Das R, Varadarajan R, Bhattacharya J, Vajpayee M, Murugavel KG, Solomon S, Sinha S, Luthra K.

Sci Rep. 2017 Mar 23;7:45163. doi: 10.1038/srep45163.


Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India.

Makhdoomi MA, Singh D, Nair Pananghat A, Lodha R, Kabra SK, Luthra K.

Virology. 2016 Dec;499:105-113. doi: 10.1016/j.virol.2016.09.011. Epub 2016 Sep 17.


IL-8 Alterations in HIV-1 Infected Children With Disease Progression.

Pananghat AN, Aggarwal H, Prakash SS, Makhdoomi MA, Singh R, Lodha R, Ali S, Srinivas M, Das BK, Pandey RM, Kabra SK, Luthra K.

Medicine (Baltimore). 2016 May;95(21):e3734. doi: 10.1097/MD.0000000000003734.


Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual.

Khan L, Makhdoomi MA, Kumar S, Nair A, Andrabi R, Clark BE, Auyeung K, Bhattacharya J, Vajpayee M, Wig N, Pantophlet R, Luthra K.

PLoS One. 2015 May 11;10(5):e0125575. doi: 10.1371/journal.pone.0125575. eCollection 2015.


Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.

Bure D, Makhdoomi MA, Lodha R, Prakash SS, Kumar R, Parray HA, Singh R, Kabra SK, Luthra K.

Viruses. 2015 Feb 10;7(2):590-603. doi: 10.3390/v7020590.


Association between GSTM1 and GSTT1 polymorphisms and esophageal squamous cell carcinoma: results from a case-control study in Kashmir, India.

Makhdoomi MA, Shah IA, Bhat GA, Amin S, Lone MM, Islami F, Dar NA.

Tumour Biol. 2015 Apr;36(4):2613-9. doi: 10.1007/s13277-014-2882-0. Epub 2014 Nov 29.


Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy.

Andrabi R, Makhdoomi MA, Kumar R, Bala M, Parray H, Gupta A, Kotnala A, Thirumurthy V, Luthra K.

J Clin Immunol. 2014 May;34(4):504-13. doi: 10.1007/s10875-014-0010-y. Epub 2014 Mar 29.


CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, Nabi S, Masood A, Lone MM, Dar NA.

Tumour Biol. 2014 Jun;35(6):5323-30. doi: 10.1007/s13277-014-1694-6. Epub 2014 Feb 8.


Contact with animals and risk of oesophageal squamous cell carcinoma: outcome of a case-control study from Kashmir, a high-risk region.

Dar NA, Islami F, Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, Lone MM, Boffetta P.

Occup Environ Med. 2014 Mar;71(3):208-14. doi: 10.1136/oemed-2013-101802. Epub 2014 Jan 9.


Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir.

Dar NA, Islami F, Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, Lone MM, Abnet CC, Boffetta P.

Br J Cancer. 2013 Sep 3;109(5):1367-72. doi: 10.1038/bjc.2013.437. Epub 2013 Jul 30.


Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir, India.

Dar NA, Shah IA, Bhat GA, Makhdoomi MA, Iqbal B, Rafiq R, Nisar I, Bhat AB, Nabi S, Masood A, Shah SA, Lone MM, Zargar SA, Islami F, Boffetta P.

Cancer Sci. 2013 Sep;104(9):1231-6. doi: 10.1111/cas.12210. Epub 2013 Jul 1.


Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India.

Dar NA, Bhat GA, Shah IA, Iqbal B, Makhdoomi MA, Nisar I, Rafiq R, Iqbal ST, Bhat AB, Nabi S, Shah SA, Shafi R, Masood A, Lone MM, Zargar SA, Najar MS, Islami F, Boffetta P.

Br J Cancer. 2012 Oct 23;107(9):1618-23. doi: 10.1038/bjc.2012.449. Epub 2012 Oct 2. Erratum in: Br J Cancer. 2013 Apr 16;108(7):1552. Kakhdoomi, M A [corrected to Makhdoomi, M A].

Supplemental Content

Loading ...
Support Center